Apnimed director Paul J. Sekhri acquires $200,000 in common shares
APMD•Director reports common share purchase and stock option grant
- Apnimed director Paul J. Sekhri reported buying 12,500 common shares at USD 16, lifting his direct holding to 12,500 shares.
- He also reported receiving stock options covering 347,264 common shares, split between USD 8.15 and USD 16 exercise prices.
